未登录 分享 收藏
分享 收藏
REWRITEeGORTEC 2018-02: Radiotherapy-durvalumab without prophylactic neck irradiation in squamous cell carcinoma of the head and neck REWRITEeGORTEC 2018-02：头颈鳞状细胞癌中放射治疗联合度伐利尤单抗且不进行预防性颈部照射 Castelli, J.; Sun, X.; Neveu, E.; Nguyen, T. V.; Tao, Y.; Martin, L.; Schick, U.; Sire, C.; Leroy, T.; Vulquin, N.; Calderon, B.; Thariat, J.; Guihard, S.; Liem, X.; Arsene, O.; Sinigaglia, L.; Campillo-Gimenez, B.; Bourhis, J. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Salvage chemotherapy after progression on nivolumab in patients with squamous cell carcinoma of the head and neck included in the phase II TOPNIVO trial Saleh, K.; Texier, M.; Iacob, M.; Daste, A.; Fayette, J.; Lefebvre, G.; Saada, E. B.; Zanetta, S.; Vinches, M.; Toullec, C.; Salas, S.; Kaminsky-Forrett, M-C.; Johnson, A. C.; Sire, C.; Khalife-saleh, N.; Ferrand, F. R.; Monard, L.; Auperin, A.; Even, C. 分享 收藏
分享 收藏
Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial Bourhis, J.; Tao, Y.; Sun, X.; Sire, C.; Martin, L.; Liem, X.; Coutte, A.; Pointreau, Y.; Thariat, J.; Miroir, J.; Rolland, F.; Kaminsky, M-C.; Borel, C.; Maillard, A.; Sinigaglia, L.; Guigay, J.; Saada-Bouzid, E.; Even, C.; Auperin, A. 分享 收藏
分享 收藏
分享 收藏
Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 PembroRad randomized trial Bourhis, J.; Sire, C.; Tao, Y.; Martin, L.; Alfonsi, M.; Prevost, J. B.; Rives, M.; Lafond, C.; Tourani, J. M.; Biau, J.; Geoffrois, L.; Coutte, A.; Liem, X.; Vauleon, E.; Drouet, F.; Pechery, A.; Guigay, J.; Wanneveich, M.; Auperin, A.; Sun, X. 分享 收藏
TOPNIVO - A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of head and neck (R/M SCCHN): Final analysis Even, C.; Daste, A.; Fayette, J.; Lefebvre, G.; Saada-Bouzid, E.; Zanetta, S.; Toullec, C.; Cupissol, D.; Salas, S.; Kaminski, M. C.; Johnson, A. C.; Vauleon, E.; Le Tourneau, C.; Sire, C.; Prevost, A.; Jallut, I.; Bourhis, J.; Guigay, J.; Auperin, A.; Texier, M. 分享 收藏
3-years follow-up of double-blind randomized phase II comparing concurrent high-dose cisplatin chemo-radiation plus xevinapant or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck Bourhis, J.; Sun, X.; Le Tourneau, C.; Pointreau, Y.; Sire, C.; Kaminsky-Forrett, M-C.; Coutte, A.; Alfonsi, M.; Boisselier, P.; Martin, L.; Delord, J-P.; Clatot, F.; Biau, J.; Rolland, F.; Gollmer, K.; Szyldergemajn, S. A.; Even, C.; Tao, Y. 分享 收藏
分享 收藏
分享 收藏
PET-based prognostic survival model after radiotherapy for head and neck cancer Castelli, Joel; Depeursinge, A.; Devillers, A.; Campillo-Gimenez, B.; Dicente, Y.; Prior, J. O.; Chajon, E.; Jegoux, F.; Sire, C.; Acosta, O.; Gherga, E.; Sun, X.; De Bari, B.; Bourhis, J.; de Crevoisier, R. 分享 收藏
分享 收藏
Switching between individual and collective motility in B lymphocytes is controlled by cell-matrix adhesion and inter-cellular interactions Rey-Barroso, Javier; Calovi, Daniel S.; Combe, Maud; German, Yolla; Moreau, Mathieu; Canivet, Astrid; Wang, Xiaobo; Sire, Clement; Theraulaz, Guy; Dupre, Loic 分享 收藏
分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
